Issa Zeinab A, Zantout Mira S, Azar Sami T
Division of Endocrinology and Metabolism, Department of Internal Medicine, American University of Beirut-Medical Center, 3 Dag Hammarskjold Plaza, 8th floor, New York, NY 10017, USA.
ISRN Endocrinol. 2011;2011:815013. doi: 10.5402/2011/815013. Epub 2011 Nov 17.
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.
多发性骨髓瘤是一种恶性浆细胞疾病，约占所有血液系统癌症的10%。其特征是克隆性浆细胞的积累，主要在骨髓中。2型糖尿病的患病率正在上升；因此，预计伴发糖尿病的多发性骨髓瘤的诊断将会增加。多发性骨髓瘤和糖尿病的治疗是多方面的。这两种疾病在患者体内并存给医生带来了重大挑战。
